3rd Quarter - Report

CEPHEID for CEPHEID

Period 3rd Quarter 2020 Filed Oct 20, 2020 Signed by Angela M. Stewart

Official filing
Firm
CEPHEID
Client
CEPHEID
Income
—
Expenses
$76,500
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to PAMA implementation (Protecting Access to Medicare Act); S. 4198, Affordable Coronavirus testing Act; issues related to diagnostics testing

LobbyistCovered position, as disclosed
MICHELE M SCHOONMAKER —
ANGELA STEWART Legislative Counsel, Senator John W. Warner (R-VA)

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 4198 (116th)

Health Issues HCR

H.R. 6102/S. 3404 the Verifying Accurate and Leading-edge IVCT Development Act (VALID), H.R. 6800, the Health Economic Recovery Omnibus Emergency Solutions Act; S. 4198 the Affordable Coronavirus Testing Act; S. 178 Delivering Immediate Relief to America's Families, Schools, and Small Business Act; S. 4231 Preparing for the Next Pandemic Act; extension of Public Health Emergency (PHE); issues related to diagnostic testing

LobbyistCovered position, as disclosed
MICHELE M SCHOONMAKER —
ANGELA STEWART Legislative Counsel, Senator John W. Warner (R-VA)

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6102 (116th), H.R. 6800 (116th), S. 4231 (116th), S. 178 (116th), S. 3404 (116th), S. 4198 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.